Celonic Group
Pharmaceutical ManufacturingBasel-stadt, Switzerland201-500 Employees
Celonic Group operates as a pure-play biologics contract development and manufacturing organization (CDMO) within pharmaceutical manufacturing. It supports biotech companies—from early-stage startups to larger organizations—in advancing biologic programs toward market approval by applying innovative bioprocessing concepts such as process intensification and full-perfusion. The company is headquartered in Basel, Basel-Stadt, Switzerland, where it runs an advanced Development and Innovation Center, and it also operates clinical and commercial GMP manufacturing facilities in Heidelberg, Germany. The organization maintains a sizable workforce to sustain its operations. Its client base consists of biotech firms seeking development and manufacturing capabilities for biologics, with the goal of bringing therapies to market efficiently. In 2025, Celonic announced a strategic partnership with Carbogen Amcis to offer fully integrated antibody-drug conjugate development and manufacturing services.